[Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma

Figure 2

The prognostic value of RPL4P4 in glioma. (a–c) The prognosis of RPL4P4 in glioma examined by TCGA databases. (d–f) The forest plot indicates the prognosis in the presence of (d) OS, (e) DFS, and (f) PFS. (g) Construction of a nomogram to predict OS. (h) The calibration curve used to display the TCGA glioma cohort for OS.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)